ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan

NAV 16.07(-0.71%)
Feb 19, 2025
ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan
AUM
₹86 Cr
Expense (%)
0.38
Turnover (%)
95.00
Benchmark
NIFTY PHARMA - TRI
Asset Quality
Large, Green
Differs from benchmark (%)
95.80

3Yr Rolling Returns(%)

Benchmark# : undefined
                                                                                                                                                            Benchmark# is
Loading...

Top 10 Holdings

Something went wrong. Please try again after sometime!
PortfolioCompare

FAQ : ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan

ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) 18.66 N/A N/A N/A
Average Rolling Returns(%) 48.83 N/A N/A N/A

The Current NAV of ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan is ₹16.07.

It is better to invest in a fund with a longer track record as ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan fund’s expense ratio is 0.38%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan is currently ₹86 Crores.

The Top three stocks are Sun Pharma Inds., Cipla and Dr. Reddys Lab and account for 46% of its portfolio. Top 5 and 10 stocks of fund account for 62% and 80% of fund’s portfolio respectively.

Top three sectors of ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan fund are Healthcare, Miscellaneous and accounting for 100% of the total portfolio.

Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Index Funds - Other it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan Fund is Index Funds - Other.

Nishit Patel and Ashwini Shinde manage the ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan Fund.

ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan current PE ratio is 39.65 and PB ratio is 5.95

The asset allocation of ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan is Stocks : 99.91%, Debt : 0.10% and Gold : 0%

The minimum SIP amount for ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan is ₹1000.00 and minimum lumpsum is ₹1000.00

The exit load for ICICI Prudential Nifty Pharma Index Fund - Growth - Direct Plan is Nil

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on